Search

Treatment of acute lymphoblastic leukemia by activation of patient's immune cells by a bispecific antibody.

Jun 13 2014 Posted in Press releases

Abstract S722
Acute lymphoblastic leukemia (ALL) is a rare type of blood cancer which is mainly treated by intensive chemotherapy.

Killer antibodies against AML

Jun 11 2016 Posted in Press releases

Most patients with acute myeloid leukemia (AML) can only be cured when a stem cell transplant induces an immune response against the patient’s leukemia.

New GFI1B variants in bleeding and platelet disorders

Jun 12 2015 Posted in Press releases

Platelets restrict blood loss upon vessel damage by formation of a clot (thrombus). Recently, we reported a family with a bleeding and platelet disorder (BPD), which was caused by a defect in the gene GFI1B1.

Dates and deadlines

You may find in this page all the dates and deadlines related to the EHA2025 Congress. All deadlines, except if mentioned differently, end at 23:59 CET/CEST.

The timelines will be updated regularly.

What to expect

FacultyThe faculty is made up of international leaders in clinical hematology research, statisticians, experts in regulatory and ethical aspects of clinical research and more.

Improved survival for adult Acute Lymphoblastic Leukemia (ALL) patients

Jun 11 2016 Posted in Press releases

Historical survival for patients 18-45 years with ALL is approximately 40 %. However the event free survival for ALL patients 18-45 years has improved to 73% following implementation of the NOPHO ALL2008 protocol in July 2008.